Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 12
1986 34
1987 34
1988 45
1989 59
1990 69
1991 67
1992 60
1993 57
1994 49
1995 58
1996 75
1997 65
1998 76
1999 89
2000 105
2001 139
2002 176
2003 260
2004 387
2005 421
2006 489
2007 548
2008 536
2009 563
2010 557
2011 602
2012 619
2013 646
2014 649
2015 636
2016 659
2017 699
2018 699
2019 691
2020 537
2021 101
Text availability
Article attribute
Article type
Publication date

Search Results

10,237 results
Results by year
Filters applied: . Clear all
Page 1
Biomarkers in Atrial Fibrillation and Heart Failure.
Oikonomou E, Zografos T, Papamikroulis GA, Siasos G, Vogiatzi G, Theofilis P, Briasoulis A, Papaioannou S, Vavuranakis M, Gennimata V, Tousoulis D. Oikonomou E, et al. Curr Med Chem. 2019;26(5):873-887. doi: 10.2174/0929867324666170830100424. Curr Med Chem. 2019. PMID: 28875838 Review.
Predisposal factors for AF include the older age, the increased left atrial size, the decreased left atrial function, the presence of heart failure and left ventricular systolic dysfunction and the presence of coronary heart disease or pulmonary or mitral val …
Predisposal factors for AF include the older age, the increased left atrial size, the decreased left atrial function, the presence of hea
Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.
Maisel AS, Duran JM, Wettersten N. Maisel AS, et al. Heart Fail Clin. 2018 Jan;14(1):13-25. doi: 10.1016/j.hfc.2017.08.002. Heart Fail Clin. 2018. PMID: 29153197 Review.
The natriuretic peptides play a vital role in normal physiology and as counter-regulatory hormones in heart failure (HF). Clinical assessment of their levels (for B-type natriuretic peptide [BNP], N-terminal proBNP, and the midregion of N …
The natriuretic peptides play a vital role in normal physiology and as counter-regulatory hormones in heart failure
Diagnosing Acute Heart Failure in the Emergency Department: A Systematic Review and Meta-analysis.
Martindale JL, Wakai A, Collins SP, Levy PD, Diercks D, Hiestand BC, Fermann GJ, deSouza I, Sinert R. Martindale JL, et al. Acad Emerg Med. 2016 Mar;23(3):223-42. doi: 10.1111/acem.12878. Epub 2016 Feb 13. Acad Emerg Med. 2016. PMID: 26910112 Free article. Review.
BACKGROUND: Acute heart failure (AHF) is one of the most common diagnoses assigned to emergency department (ED) patients who are hospitalized. ...METHODS: PubMed, EMBASE, and selected bibliographies were searched from January 1965 to March 2015 using MeSH ter …
BACKGROUND: Acute heart failure (AHF) is one of the most common diagnoses assigned to emergency department (ED) patient …
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G. Pieske B, et al. Eur Heart J. 2019 Oct 21;40(40):3297-3317. doi: 10.1093/eurheartj/ehz641. Eur Heart J. 2019. PMID: 31504452 Free article.
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. ...Elevated natriuretic peptides support, but normal levels do not exclude a diagnosis of HFpEF. ...
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. ...Eleva …
Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors.
Alawieh H, Chemaly TE, Alam S, Khraiche M. Alawieh H, et al. Sensors (Basel). 2019 Nov 16;19(22):5003. doi: 10.3390/s19225003. Sensors (Basel). 2019. PMID: 31744130 Free PMC article. Review.
Heart failure is a class of cardiovascular diseases that remains the number one cause of death worldwide with a substantial economic burden of around $18 billion incurred by the healthcare sector in 2017 due to heart failure hospitalization and disease
Heart failure is a class of cardiovascular diseases that remains the number one cause of death worldwide with a substantial ec
Diagnosis of heart failure: the new classification of heart failure.
Nussbaumerová B, Rosolová H. Nussbaumerová B, et al. Vnitr Lek. 2018 Fall;64(9):847-851. Vnitr Lek. 2018. PMID: 30441997 English.
Natriuretic peptides have a significant nega-tive predictive value for excluding of heart failure. ...A quantity of examination methods is available in heart failure diagnosis and treatment. Key words: classification - diagnosis
Natriuretic peptides have a significant nega-tive predictive value for excluding of heart failure. ...A quantity
The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting.
Roberts E, Ludman AJ, Dworzynski K, Al-Mohammad A, Cowie MR, McMurray JJ, Mant J; NICE Guideline Development Group for Acute Heart Failure. Roberts E, et al. BMJ. 2015 Mar 4;350:h910. doi: 10.1136/bmj.h910. BMJ. 2015. PMID: 25740799 Free PMC article. Review.
OBJECTIVES: To determine and compare the diagnostic accuracy of serum natriuretic peptide levels (B type natriuretic peptide, N terminal probrain natriuretic peptide (NTproBNP), and mid-regional proatrial natriuretic peptide
OBJECTIVES: To determine and compare the diagnostic accuracy of serum natriuretic peptide levels (B type natriuretic
Angiotensin Receptor-Neprilysin Inhibitors and the Natriuretic Peptide Axis.
Vasquez N, Carter S, Grodin JL. Vasquez N, et al. Curr Heart Fail Rep. 2020 Jun;17(3):67-76. doi: 10.1007/s11897-020-00458-y. Curr Heart Fail Rep. 2020. PMID: 32394149 Review.
PURPOSE OF THE REVIEW: The purpose of this review is to describe the effects of angiotensin receptor neprilysin inhibitor (ARNI) therapy on the natriuretic peptide axis (NPA), with a particular focus on B-type natriuretic peptide (BNP), atrial natri
PURPOSE OF THE REVIEW: The purpose of this review is to describe the effects of angiotensin receptor neprilysin inhibitor (ARNI) therapy on …
Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.
Abuzaanona A, Lanfear D. Abuzaanona A, et al. Curr Heart Fail Rep. 2017 Dec;14(6):536-542. doi: 10.1007/s11897-017-0365-5. Curr Heart Fail Rep. 2017. PMID: 29075957 Free PMC article. Review.
PURPOSE OF REVIEW: Heart failure (HF) continues to be a public health burden despite advances in therapy, and the natriuretic peptide (NP) system is clearly of critical importance in this setting, spawning valuable diagnostic and prognostic testing, su …
PURPOSE OF REVIEW: Heart failure (HF) continues to be a public health burden despite advances in therapy, and the natriuret
Non-natriuretic peptide biomarkers in heart failure with preserved and reduced ejection fraction.
Oikonomou E, Vogiatzi G, Tsalamandris S, Mourouzis K, Siasos G, Lazaros G, Skotsimara G, Marinos G, Vavuranakis M, Tousoulis D. Oikonomou E, et al. Biomark Med. 2018 Jul;12(7):783-797. doi: 10.2217/bmm-2017-0376. Epub 2018 Jun 5. Biomark Med. 2018. PMID: 29865857 Review.
Heart failure (HF) with reduced and preserved ejection fraction constitutes two entities with distinct pathogenetic backgrounds sharing common features. Beyond natriuretic peptides, several novel biomarkers have been proven useful in the diagnosis
Heart failure (HF) with reduced and preserved ejection fraction constitutes two entities with distinct pathogenetic background
10,237 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page